Fridley, Minn. - The FDA approved Medtronic's new integrated insulin pump with real-time glucose monitoring for diabetes patients, the company announced April 13. The MiniMed Paradigm Real-Time Insulin Pump and Continuous Glucose Monitoring System uses a tiny electrode sensor to measure glucose levels every five minutes.
Comments